What is PALX's health score?

Palomino Laboratories Inc. (PALX) has a TradeApes health score of 40 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is PALX's estimated fair value?

Based on our 5-year discounted cash flow model, Palomino Laboratories Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is PALX undervalued or overvalued?

Our model currently rates PALX as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for PALX... Refresh in a moment for the full analysis.

Palomino Laboratories Inc. (PALX)

Technology Inconclusive inconclusive weak

Updated: 2026-06-05

TradeApes Score

Financial Strength

35 Weak

Operating Trend

30 Weak

Relative Value

50 Mixed

Capital Allocation

30 Weak

Risk

65 Healthy

Key Findings

+ Strong liquidity — current assets more than 2× current liabilities

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.